ORLADEYO (berotralstat) for the Treatment of Hereditary Angioedema (HAE)

Image 1-ORLADEYO (berotralstat)
ORLADEYO is an oral medicine indicated for adults and children 12 years of age and older to prevent attacks of Hereditary Angioedema (HAE). Credit: Biocryst Pharmaceuticals, Inc.